Nabriva Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.4%.

Top 22 shareholders own 8.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.59%	Lincoln Park Capital, LLC	180,504	€87.5k	0%	2.53%
0.84%	Values First Advisors, Inc.	27,262	€13.2k	2.17%	0.01%
0.71%	Renaissance Technologies LLC	22,861	€11.1k	-2.14%	no data
0.43%	ACATIS Investment GmbH	14,000	€6.8k	0%	no data
0.26%	Theodore Schroeder	8,483	€4.1k	0%	no data
0.17%	Morgan Stanley, Investment Banking and Brokerage Investments	5,351	€2.6k	30.3%	no data
0.062%	Triad Hybrid Solutions, LLC	2,000	€969.5	0%	no data
0.042%	Colin Broom	1,369	€663.6	0%	no data
0.041%	Steven Gelone	1,323	€641.4	0%	no data
0.019%	Charles Rowland	610	€295.7	0%	no data
0.017%	BBVA Asset Management, S.A., S.G.I.I.C	565	€273.9	0%	no data
0.014%	Stephen Webster	456	€221.0	0%	no data
0.013%	Daniel Burgess	415	€201.1	0%	no data
0.012%	Carrie Bourdow	396	€192.0	0%	no data
0.011%	Lisa Dalton	364	€176.5	0%	no data
0.0089%	Mark H. Corrigan	288	€139.5	0%	no data
0.0026%	Merrill Lynch & Co. Inc., Banking Investments	84	€40.7	0%	no data
0.0012%	Wells Fargo & Company, Securities and Brokerage Investments	40	€19.4	0%	no data
0.00062%	RBC Dominion Securities Inc., Asset Management Arm	20	€9.7	0%	no data
0.00025%	Securities America Advisors, Inc.	8	€3.9	0%	no data
0.00025%	Addison Advisors LLC	8	€3.9	0%	no data
0.00006%	Royal Bank of Canada, Banking & Securities Investments	2	€0.9	0%	no data